课题基金 / 基金详情

Role of SOCS1 in maintaining prostate homeostasis and in suppressing malignant growth

Role of SOCS1 in maintaining prostate homeostasis and in suppressing malignant growth
SOCS1 在维持前列腺稳态和抑制恶性生长中的作用
批准号:
447518
负责人:
Ilangumaran Subburaj
金额:
$7.29万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-04-01 至 2022-04-01

项目摘要

项目成果

Ilangumaran Subburaj的其他基金

相似基金

相关文献

中文摘要
翻译
众所周知的前列腺癌的危险因素是种族和家族史。然而,仅遗传改变的基因不足以引起疾病。老年是另一个危险因素,它通过增加癌症的发病率而促进癌症的发展。
英文摘要
The well-known risk factors of prostate cancer are ethnicity and family history. However, inheritance of the altered genes alone is not sufficient to cause disease. Old age is another risk factor that contributes to cancer development through increasing t
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of the hepatic fibrogenic response by Suppressor of cytokine signaling (SOCS) proteins
  • 批准号:
    357256
  • 项目类别:
    Operating Grants
  • 资助金额:
    $54.45万
  • 财政年份:
    2016
  • 负责人:
    Ilangumaran Subburaj
  • 依托单位:
Tumor suppressor mechanisms of SOCS proteins in hepatocellular carcinoma
  • 批准号:
    357777
  • 项目类别:
    Operating Grants
  • 资助金额:
    $52.67万
  • 财政年份:
    2016
  • 负责人:
    Ilangumaran Subburaj
  • 依托单位:
CIACCO-2016 (5th Annual symposium on Cytokines in Inflammation, Ageing, CanCer and Obesity)
  • 批准号:
    324968
  • 项目类别:
    Miscellaneous Programs
  • 资助金额:
    $0.73万
  • 财政年份:
    2015
  • 负责人:
    Ilangumaran Subburaj
  • 依托单位:
Tumor immunotherapy: enhancing the efficacy of cytotoxic T lymphocytes by IL-21 and IL-15
  • 批准号:
    200968
  • 项目类别:
    Operating Grants
  • 资助金额:
    $25.04万
  • 财政年份:
    2010
  • 负责人:
    Ilangumaran Subburaj
  • 依托单位:
海外基金